3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.

scientific article published on 20 April 2017

3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1084972388
P356DOI10.1038/NPP.2017.80
P932PMC publication ID5561347
P698PubMed publication ID28425496

P50authorAdelaide R MinervaQ87871269
P2093author name stringKenner C Rice
Leonard L Howell
Agnieszka Sulima
Jordan N Kohn
Elizabeth G Pitts
Meghan T Logun
Erika B Chandler
P2860cites workThe safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot studyQ24606265
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up studyQ24620135
Adult birdsong is actively maintained by error correction.Q24657611
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional couplingQ25001700
Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humansQ26859367
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorderQ27015917
Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)Q27329826
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotoninQ28143430
No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activationQ28540131
A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy")Q28577690
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activityQ28582332
Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptorsQ28727300
Observational study of behavior: sampling methodsQ29547830
Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeysQ33750819
Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humansQ33866538
Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeysQ34035262
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.Q34495787
Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaquesQ34552306
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptorsQ34558760
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.Q34989613
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primatesQ35590703
Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methyleneQ37161392
Sertraline effects on cerebrospinal fluid monoamines and species-typical socioemotional behavior of female cynomolgus monkeysQ37638436
Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Q38048826
Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functionsQ38099540
Vocalization as an emotional indicator. A neuroethological study in the squirrel monkeyQ39681642
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasyQ40359394
Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeysQ40444221
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamineQ40513141
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamineQ42491091
The behavioral repertoire of the squirrel monkey (Saimiri).Q43318153
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopramQ43842041
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humansQ43842050
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motilityQ44599215
Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbensQ48138239
Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis studyQ48340449
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice.Q48437323
MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.Q49064161
Disruption of primate social behavior by d-amphetamine and cocaine: Differential antagonism by antipsychoticsQ51864369
The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys.Q52169847
Analysis of amphetamine effects on agonistic and affiliative behavior in squirrel monkeys (Saimiri sciureus).Q52505322
Three points to consider when choosing a LM or GLM test for count dataQ57239134
P433issue10
P407language of work or nameEnglishQ1860
P304page(s)1962-1971
P577publication date2017-04-20
P1433published inNeuropsychopharmacologyQ2261280
P1476title3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner
P478volume42

Reverse relations

cites work (P2860)
Q47777762(±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA.
Q89231003Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys
Q57176236Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine
Q47662199Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice
Q38600048Serotonin and brain function: a tale of two receptors

Search more.